Argenx halts efgartigimod Phase 3 in Sjögren’s
FDA keeps Newron hold, Zealand’s petrelintide Phase 2 win, Bavarian Nordic lifts guidance, UK pulls Valneva’s IXCHIQ.
Argenx halts efgartigimod Phase 3 in Sjögren’s Read Post »
FDA keeps Newron hold, Zealand’s petrelintide Phase 2 win, Bavarian Nordic lifts guidance, UK pulls Valneva’s IXCHIQ.
Argenx halts efgartigimod Phase 3 in Sjögren’s Read Post »